Testing the Engaged Approach to Lung Cancer Screening

Last updated: April 15, 2025
Sponsor: University of Colorado, Denver
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lung Cancer

Non-small Cell Lung Cancer

Cancer

Treatment

Engaged Approach to Lung Cancer Screening

Clinical Study ID

NCT06327074
21-3063.cc
  • Ages > 18
  • All Genders

Study Summary

The goal of this study is to assess feasibility and acceptability of the Engaged Approach to Lung Cancer Screening (EA-LCS) in diverse lung cancer screening (LCS) programs operating in a variety of geographic regions across Colorado and the US.

Eligibility Criteria

Inclusion

Inclusion Criteria:

The trial incorporates a multilevel assessment and enrollment involves inclusion criteria at two levels: (1) LCS Program and (2) LCS Program Staff member.

Program inclusion criteria (n = up to 8 sites):

  • Must conduct at least 50 low-dose computed tomography (LDCT) scans per year (baseline + follow-up)

  • Must be able to identify a primary contact person for LCS program operations (e.g.,program coordinator, program navigator, program manager, etc.)

Staff member inclusion criteria (n ~ 5 at each site/~40 participants total):

  • Identified staff member of the LCS program site

  • >18 years of age

  • Must be able to complete study surveys and interviews in English

  • Willing to provide informed consent

Exclusion

Exclusion Criteria:

  • none

Study Design

Total Participants: 40
Treatment Group(s): 1
Primary Treatment: Engaged Approach to Lung Cancer Screening
Phase:
Study Start date:
March 11, 2024
Estimated Completion Date:
December 31, 2026

Connect with a study center

  • University of Colorado Hospital

    Denver, Colorado 80045
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.